Literature DB >> 24795046

Cancer-relevant splicing factor CAPERα engages the essential splicing factor SF3b155 in a specific ternary complex.

Sarah Loerch1, Alexandre Maucuer2, Valérie Manceau3, Michael R Green3, Clara L Kielkopf4.   

Abstract

U2AF homology motifs (UHMs) mediate protein-protein interactions with U2AF ligand motifs (ULMs) of pre-mRNA splicing factors. The UHM-containing alternative splicing factor CAPERα regulates splicing of tumor-promoting VEGF isoforms, yet the molecular target of the CAPERα UHM is unknown. Here we present structures of the CAPERα UHM bound to a representative SF3b155 ULM at 1.7 Å resolution and, for comparison, in the absence of ligand at 2.2 Å resolution. The prototypical UHM/ULM interactions authenticate CAPERα as a bona fide member of the UHM family of proteins. We identify SF3b155 as the relevant ULM-containing partner of full-length CAPERα in human cell extracts. Isothermal titration calorimetry comparisons of the purified CAPERα UHM binding known ULM-containing proteins demonstrate that high affinity interactions depend on the presence of an intact, intrinsically unstructured SF3b155 domain containing seven ULM-like motifs. The interplay among bound CAPERα molecules gives rise to the appearance of two high affinity sites in the SF3b155 ULM-containing domain. In conjunction with the previously identified, UHM/ULM-mediated complexes of U2AF(65) and SPF45 with SF3b155, this work demonstrates the capacity of SF3b155 to offer a platform for coordinated recruitment of UHM-containing splicing factors.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Crystal Structure; Gene Regulation; Protein Domain; Protein Structure and Folding; Protein-Protein Interaction; RNA Splicing

Mesh:

Substances:

Year:  2014        PMID: 24795046      PMCID: PMC4067167          DOI: 10.1074/jbc.M114.558825

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  PUF60: a novel U2AF65-related splicing activity.

Authors:  P S Page-McCaw; K Amonlirdviman; P A Sharp
Journal:  RNA       Date:  1999-12       Impact factor: 4.942

2.  Molecular cloning and characterization of CAPER, a novel coactivator of activating protein-1 and estrogen receptors.

Authors:  Dong-Ju Jung; Soon-Young Na; Doe Sun Na; Jae Woon Lee
Journal:  J Biol Chem       Date:  2001-11-09       Impact factor: 5.157

3.  A novel peptide recognition mode revealed by the X-ray structure of a core U2AF35/U2AF65 heterodimer.

Authors:  C L Kielkopf; N A Rodionova; M R Green; S K Burley
Journal:  Cell       Date:  2001-09-07       Impact factor: 41.582

4.  Protein composition of human prespliceosomes isolated by a tobramycin affinity-selection method.

Authors:  Klaus Hartmuth; Henning Urlaub; Hans-Peter Vornlocher; Cindy L Will; Marc Gentzel; Matthias Wilm; Reinhard Lührmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-11       Impact factor: 11.205

5.  PHENIX: building new software for automated crystallographic structure determination.

Authors:  Paul D Adams; Ralf W Grosse-Kunstleve; Li Wei Hung; Thomas R Ioerger; Airlie J McCoy; Nigel W Moriarty; Randy J Read; James C Sacchettini; Nicholas K Sauter; Thomas C Terwilliger
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-10-21

Review 6.  SF3B1 mutations in chronic lymphocytic leukemia.

Authors:  Youzhong Wan; Catherine J Wu
Journal:  Blood       Date:  2013-04-08       Impact factor: 22.113

7.  Specific Ser-Pro phosphorylation by the RNA-recognition motif containing kinase KIS.

Authors:  A Maucuer; J P Le Caer; V Manceau; A Sobel
Journal:  Eur J Biochem       Date:  2000-07

8.  Analysis Tool Web Services from the EMBL-EBI.

Authors:  Hamish McWilliam; Weizhong Li; Mahmut Uludag; Silvano Squizzato; Young Mi Park; Nicola Buso; Andrew Peter Cowley; Rodrigo Lopez
Journal:  Nucleic Acids Res       Date:  2013-05-13       Impact factor: 16.971

9.  Structure, phosphorylation and U2AF65 binding of the N-terminal domain of splicing factor 1 during 3'-splice site recognition.

Authors:  Yun Zhang; Tobias Madl; Ivona Bagdiul; Thomas Kern; Hyun-Seo Kang; Peijian Zou; Nina Mäusbacher; Stephan A Sieber; Angela Krämer; Michael Sattler
Journal:  Nucleic Acids Res       Date:  2012-11-21       Impact factor: 16.971

10.  Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma.

Authors:  J William Harbour; Elisha D O Roberson; Hima Anbunathan; Michael D Onken; Lori A Worley; Anne M Bowcock
Journal:  Nat Genet       Date:  2013-01-13       Impact factor: 38.330

View more
  25 in total

Review 1.  Altered RNA Processing in Cancer Pathogenesis and Therapy.

Authors:  Esther A Obeng; Connor Stewart; Omar Abdel-Wahab
Journal:  Cancer Discov       Date:  2019-10-14       Impact factor: 39.397

2.  UHM-ULM interactions in the RBM39-U2AF65 splicing-factor complex.

Authors:  Galina A Stepanyuk; Pedro Serrano; Eigen Peralta; Carol L Farr; Herbert L Axelrod; Michael Geralt; Debanu Das; Hsiu-Ju Chiu; Lukasz Jaroszewski; Ashley M Deacon; Scott A Lesley; Marc-André Elsliger; Adam Godzik; Ian A Wilson; Kurt Wüthrich; Daniel R Salomon; James R Williamson
Journal:  Acta Crystallogr D Struct Biol       Date:  2016-03-24       Impact factor: 7.652

3.  U2AF65 assemblies drive sequence-specific splice site recognition.

Authors:  Manel Tari; Valérie Manceau; Jean de Matha Salone; Asaki Kobayashi; David Pastré; Alexandre Maucuer
Journal:  EMBO Rep       Date:  2019-07-04       Impact factor: 8.807

4.  Protein 4.1R Exon 16 3' Splice Site Activation Requires Coordination among TIA1, Pcbp1, and RBM39 during Terminal Erythropoiesis.

Authors:  Shu-Ching Huang; Henry S Zhang; Brian Yu; Ellen McMahon; Dan T Nguyen; Faye H Yu; Alexander C Ou; Jennie Park Ou; Edward J Benz
Journal:  Mol Cell Biol       Date:  2017-04-14       Impact factor: 4.272

5.  The pre-mRNA splicing and transcription factor Tat-SF1 is a functional partner of the spliceosome SF3b1 subunit via a U2AF homology motif interface.

Authors:  Sarah Loerch; Justin R Leach; Steven W Horner; Debanjana Maji; Jermaine L Jenkins; Mary J Pulvino; Clara L Kielkopf
Journal:  J Biol Chem       Date:  2018-12-19       Impact factor: 5.157

6.  SF1 Phosphorylation Enhances Specific Binding to U2AF65 and Reduces Binding to 3'-Splice-Site RNA.

Authors:  Rakesh Chatrikhi; Wenhua Wang; Ankit Gupta; Sarah Loerch; Alexandre Maucuer; Clara L Kielkopf
Journal:  Biophys J       Date:  2016-12-20       Impact factor: 4.033

7.  Quarterly intrinsic disorder digest (April-May-June, 2014).

Authors:  Shelly DeForte; Vladimir N Uversky
Journal:  Intrinsically Disord Proteins       Date:  2017-03-01

8.  Selective degradation of splicing factor CAPERα by anticancer sulfonamides.

Authors:  Taisuke Uehara; Yukinori Minoshima; Koji Sagane; Naoko Hata Sugi; Kaoru Ogawa Mitsuhashi; Noboru Yamamoto; Hiroshi Kamiyama; Kentaro Takahashi; Yoshihiko Kotake; Mai Uesugi; Akira Yokoi; Atsushi Inoue; Taku Yoshida; Miyuki Mabuchi; Akito Tanaka; Takashi Owa
Journal:  Nat Chem Biol       Date:  2017-04-24       Impact factor: 15.040

9.  Aberrant RNA Splicing in Cancer.

Authors:  Luisa Escobar-Hoyos; Katherine Knorr; Omar Abdel-Wahab
Journal:  Annu Rev Cancer Biol       Date:  2018-11-28

Review 10.  Biology of the mRNA Splicing Machinery and Its Dysregulation in Cancer Providing Therapeutic Opportunities.

Authors:  Maxime Blijlevens; Jing Li; Victor W van Beusechem
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.